The Space Act, which would apply to local and foreign companies, aims to simplify procedures, protect assets in orbit, level the playing field, and help European companies expand into new markets.
Nearly 12 million people could lose health care coverage if the bill gets passed and signed by Trump, while hospitals would be hit hard by Medicaid cuts.
RFK Jr.’s vaccine advisory board could stop recommending some routine childhood immunizations, leaving insurers to decide whether to still cover them. For now, most are remaining tight-lipped.
The World Health Organization has added the variant, known formally as XFG, to its monitoring list. A dry, irritated throat is among its main symptoms.
President Donald Trump’s budget would kill off tax credits for wind and solar, raising costs for new clean energy projects and blowing up valuable investment in those already in the pipeline.
Records of hundreds of emergency calls from ICE detention centers obtained by WIRED—including audio recordings—show a system inundated by life-threatening incidents, delayed treatment, and overcrowding.
The versatile cannabis plant could, some scientists think, one day be useful for lunar and Martian colonists. For now, researchers will subject its seeds to radiation in orbit and see what happens.
The Vera C. Rubin Observatory is poised to discover billions of new astronomical objects, revolutionizing understanding of everything from the history of the solar system to the workings of dark energy.
Remote-sensing data and artificial intelligence are mapping the most heat-vulnerable buildings in cities like Delhi, in an effort to target relief from extreme temperatures at a granular level.
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and Ozempic for weight loss and lowering blood sugar.
The International Energy Agency estimates that 70 percent of the fossil fuel sector’s methane emissions could be cut with existing technologies—many of which would save polluters money.
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.
A growing body of research attempts to put a number on energy use and AI—even as the companies behind the most popular models keep their carbon emissions a secret.
In United States v. Skrmetti, the Supreme Court ruled that Tennessee’s ban on gender-affirming care for minors was not unconstitutional—the first case of its kind on which the court has ruled.
A new study reveals the key lies not in the production of a regrowth molecule, but in that molecule's controlled destruction. The discovery could inspire future regenerative medicine.
Jules Gill-Peterson doesn’t want to fight for trans joy. She wants to fight for what trans people really need: resources, hormones, and surgery. Her latest arena? The US Supreme Court.
An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.
Connexion
Wired
